NCT07517887 Anti-aging Efficacy Study on One Cosmetic Product Containing Mitopure
| NCT ID | NCT07517887 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Amazentis SA |
| Condition | Aging |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-04-22 |
| Primary Completion | 2026-10-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-04-22 with a primary completion date of 2026-10-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to investigate the impact of a topical product on skin health and aging
Eligibility Criteria
INCLUSION CRITERIA * Written Informed Consent to participate in the study * Written Informed Consent for the use of the images for marketing purposes applies to subgroup participants of study 26.0112. * Willingness to actively participate in the study and to come to the scheduled visits * Female * Male, approximately 10 to 15% with little facial hair * From 45 to 65 years of age * Healthy skin in the test areas * Visible wrinkles in the face (grade 3 to 6 according to proderm wrinkle score) Exclusion criteria * Female participants: Pregnancy or lactation * Drug addicts, alcoholics * AIDS, HIV-positive or infectious hepatitis * Conditions which exclude a participation or might influence the test reaction/evaluation * Participation or being in the waiting period after participation in cosmetic and/or pharmaceutical studies pertaining to the test area * Active skin disease at the test area * Documented allergies to face/eye care products or their ingredients * Diabetes mellitus * Cancer not being diagnosed as cured and requiring chemotherapy, irradiation and/or hormonal treatment within the last 2 years * One of the following illnesses with reduced physical capability/fitness: asthma (symptom-free allergic asthma is not an exclusion criterion), hypertension (if not adjusted with medication), cardiovascular diseases * Epilepsy * Wounds, moles, tattoos, scars, irritated skin, excessive hair growth, freckles, etc. at the test area that could influence the investigation * Regular use of tanning beds within the last 6 weeks prior to the start of the study * Any topical medication at the test area within the last 3 days prior to the start of the study * Systemic therapy with immuno-suppressive drugs (e.g. corticosteroids) and/or antihistamines (e.g. antiallergics) within the last 7 days prior to the start of the study and throughout the entire course of the study that in the opinion of the investigator may affect the outcome of the study * Therapy with antibiotics within the last 2 weeks prior to the start of the study and throughout the entire course of the study that in the opinion of the investigator may affect the outcome of the study * Cosmetic surgery procedure in the test area (e.g. laser, facelift) within the last 2 years and throughout the entire course of the study * Cosmetic surgery treatments in the test area, e.g. IPL (Intensed Pulsed Light), botox, chemical peel, dermabrasion within the last 2 years prior to the start of the study and throughout the entire course of the study * Medical treatment for wrinkle reduction (e.g. peeling with vitamin A or fruit acids) on the face within the last 2 weeks prior to the start of the study and throughout the entire course of the study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07517887 clinical trial?
This trial is open to participants of all sexes, aged 45 Years or older, up to 65 Years, studying Aging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07517887 currently recruiting?
Yes, NCT07517887 is actively recruiting participants. Contact the research team at bcurrier@timeline.com for enrollment information.
Where is the NCT07517887 trial being conducted?
This trial is being conducted at Schenefeld, Germany.
Who is sponsoring the NCT07517887 clinical trial?
NCT07517887 is sponsored by Amazentis SA. The trial plans to enroll 30 participants.